Clinical Trials on Cholesterol Ester Storage Disease in Taiwan

Total 257 results

Sanofi

Recruiting

Agalsidase Beta Long-Term Treatment Outcome for Fabry Disease Patients With IVS4 Mutation in Taiwan

Fabry Disease

Taiwan
Ping-Yen Liu

Unknown

Platelet Resistance With Ticagrelor or Standard-Dose Clopidogrel Among CKD and ACS Patients (APROVE-CKD)

Chronic Kidney Disease | Acute Coronary Syndrome | End-Stage Renal Disease

Taiwan
National Cheng-Kung University Hospital

Completed

Vascular Protective Effect of Rosuvastatin in Arteriovenous Fistula

Diabetes Mellitus | Arteriovenous Fistula | End-stage Kidney Disease

Taiwan
National Cheng-Kung University Hospital

Completed

Genomic Study in Non-small Cell Lung Cancer Brain Metastasis

Brain Metastases | NSCLC Stage IV

Taiwan
Taipei Veterans General Hospital, Taiwan

Unknown

Effect of Motor Development, Motor Function and Electrophysiologic Findings of IOPD Under ERT

Glycogen Storage Disease Type II

Taiwan
National Taiwan University Hospital

Recruiting

High Risk Screen of Childhood Late-onset Pompe Disease in Pediatric Outpatient Clinics

Pompe Disease

Taiwan
National Taiwan University Hospital

Recruiting

A Long-term Study for the Outcome of Pompe Disease

Pompe Disease

Taiwan
National Taiwan University Hospital

Completed

Evaluation of Salbutamol as an Adjuvant Therapy for Pompe Disease

Pompe Disease

Taiwan
National Taiwan University Hospital

Unknown

Muscle Response to Enzyme Replacement Therapy in Pompe Disease

Pompe Disease

Taiwan
National Taiwan University Hospital

Completed

Newborn Screening Assay of Pompe's Disease

Pompe Disease

Taiwan
National Taiwan University Hospital

Unknown

A Long Term Follow up Study in Late-onset Pompe Disease

Pompe Disease

Taiwan
National Taiwan University Hospital

Unknown

Immune Modulation Therapy for Pompe Disease

Pompe Disease

Taiwan
National Taiwan University Hospital

Unknown

CPAP for Infantile Pompe Disease

Pompe Disease

Taiwan
Genzyme, a Sanofi Company

Completed

Extension Study of Patients With Infantile-Onset Pompe Disease Who Were Previously Enrolled in Protocol AGLU01602

Glycogen Storage Disease Type II

United States, France, Germany, Israel, Italy, Netherlands, Taiwan
LMU Klinikum
Genzyme, a Sanofi Company

Completed

Long-term Outcome in Late-onset Pompe Disease Treated Beyond 36 Months (STIG-Pompe-Study) (STIG)

Pompe Disease

Germany, Taiwan, Italy
National Taiwan University Hospital
Sanofi

Completed

Eliglustat on Gaucher Disease Type IIIB

Gaucher Disease, Type III

Taiwan
National Taiwan University Hospital
Actelion

Unknown

Miglustat on Gaucher Disease Type IIIB

Gaucher Disease

Taiwan
Amicus Therapeutics

Available

Expanded Access for ATB200/AT2221 for the Treatment of IOPD

Pompe Disease Infantile-Onset

Taiwan, United States, Italy
National Taiwan University Hospital

Recruiting

The Natural History of Sialidosis Type I

Observational Study

Taiwan
Mackay Memorial Hospital

Recruiting

Biomarkers and Cardiac Imaging Diagnostic Assay for Monitoring Patients With Fabry Disease

Fabry Disease

Taiwan
Chung-Hsing Wang
Sanofi

Not yet recruiting

Screening for Gaucher Disease and Acid Sphingomyelinase Deficiency

Gaucher Disease

Taiwan
Chang Gung Memorial Hospital
Sanofi

Unknown

Fabry Disease in Cerebrovascular Disease

Fabry Disease

Taiwan
Genzyme, a Sanofi Company

Active, not recruiting

A Study to Assess Safety and Efficacy of Avalglucosidase Alfa Administered Every Other Week in Pediatric Patients With Infantile-onset Pompe Disease Previously Treated With Alglucosidase Alfa (Mini-COMET)

Glycogen Storage Disease Type II-Pompe's Disease

United States, France, Japan, Taiwan, United Kingdom
Chang Gung Memorial Hospital

Recruiting

Epidemiological Study of Fabry Disease Screening in Chronic Kidney Disease Patients

Fabry Disease

Taiwan
Taipei Veterans General Hospital, Taiwan

Unknown

Far Infrared Therapy on Peritoneal Function of CAPD Patients (CAPD)

End-stage Renal Disease

Taiwan
China Medical University Hospital

Unknown

Low Potassium Content Vegetables in End-Stage Renal Disease

End-stage Renal Disease

Taiwan
Amicus Therapeutics

Recruiting

A Study to Evaluate the Safety, Efficacy, PK, PD and Immunogenicity of Cipaglucosidase Alfa/Miglustat in IOPD Subjects Aged 0 to <18 (ROSSELLA)

Glycogen Storage Disease Type II Infantile Onset

United States, Taiwan, France, Germany, Italy, United Kingdom
Chang Gung Memorial Hospital

Recruiting

Physical Fitness/Training and Inflammatory Immune Responses in Patients With End-stage Renal Disease

End-stage Renal Disease

Taiwan
National Taiwan University Hospital

Unknown

Circulating lncRNA and CV Morbidities in CKD and ESRD

Chronic Kidney Disease | End-stage Renal Disease

Taiwan
Kaohsiung Medical University Chung-Ho Memorial...
National Sun Yat-sen University

Recruiting

Use of a Novel Artificial Intelligence Assisted Platform to Assess Optimal Dosing and Treatment Strategy of Erythropoiesis-stimulating Agents (ESA) in Hemodialysis Patients (AI)

End Stage Renal Disease on Dialysis

Taiwan
Genzyme, a Sanofi Company

Completed

A Study of the Safety and Efficacy of rhGAA in Patients With Infantile-onset Pompe Disease

Glycogen Storage Disease Type II

United States, Taiwan, Israel, United Kingdom, France
Far Eastern Memorial Hospital

Unknown

Immediate Maintained Cannulation of a Newly Implanted Prosthetic Arteriovenous Access for Acute Hemodialysis

End-Stage Renal Disease | Prosthetic Arteriovenous Access

Taiwan
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical...
Taipei Veterans General Hospital, Taiwan

Withdrawn

Aspirin in the Prevention of Cardiovascular Events in Hemodialysis Patients

End-Stage Renal Disease

Taiwan
National Taiwan University Hospital
Mrs. Hsiu-Chin Lee Kidney Research Fund

Unknown

High Flux Hemodialysis Thrice Versus Once

End-Stage Renal Disease

Taiwan
Camillians Saint Mary's Hospital Luodong

Unknown

The Influences of Dialysate Bicarbonate Concentrations on Hemodialysis Patients

End Stage Renal Disease on Dialysis

Taiwan
China Medical University Hospital

Recruiting

Renal Replacement Therapies Decision Aids

Renal Replacement Therapy | End-stage Renal Disease | Decision Aid | Decision-making

Taiwan
National Taiwan University Hospital

Completed

Application of Wearable Devices to Build a Self-Management Model in Chronic Kidney Disease Patients

Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1

Taiwan
4D Molecular Therapeutics

Active, not recruiting

4D-310 in Adults With Fabry Disease and Cardiac Involvement

Fabry Disease

Taiwan, Australia
Mackay Memorial Hospital
Sanofi Taiwan Co. Ltd

Recruiting

The Intensively Follow-up Examinations for Asymptomatic MPS I Infants in Taiwan

MPS I

Taiwan
National Taiwan University Hospital

Unknown

Effect of Different Hemodialysis Modality on Adiponectin,Vascular Function and Clinical Prognosis

End-Stage Renal Disease

Taiwan
Chang Gung Memorial Hospital

Completed

Supplements SMOF in TPN for Liver Transplantation Recipients

Liver Transplantation | End-stage Liver Disease | Total Parenteral Nutrition

Taiwan
Astellas Gene Therapies

Recruiting

A Study About Antibody Levels and Biomarkers in the Blood in People With Late-onset Pompe Disease

Pompe Disease (Late-onset)

United States, Spain, France, Taiwan, Italy
Kaohsiung Medical University Chung-Ho Memorial...

Unknown

Iron Therapy in Patients With End-Stage Renal Disease

Inflammation | Anemia | Cardiovascular Risk Factor | End-stage Renal Disease

Taiwan
National Taiwan University Hospital

Completed

Application of Miglustat in Patients With Niemann-Pick Type C

Niemann-Pick Disease Type C

Taiwan
Microbio Co Ltd

Recruiting

Safety and Potential Efficacy of MS-20 In Combination With Pembrolizumab for the Treatment of NSCLC

NSCLC Stage IV

Taiwan
National Taiwan University Hospital

Withdrawn

The Hemodynamic Effects During Sustained Low-efficiency Dialysis Versus Continuous Veno-venous Hemofiltration for Patients With Intracranial Hypertension in a Cross Over Study (NSARF)

End- Stage Renal Disease Patients

Taiwan
Far Eastern Memorial Hospital

Active, not recruiting

The Life Style Patterns and the Development Trend of Chronic Diseases in Healthy and Sub-healthy Groups Were Analyzed by Using Data-mining Techniques

Metabolic Syndrome | Chronic Disease | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease Stage 3 | Chronic Kidney Disease Stage 4 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1

Taiwan
Far Eastern Memorial Hospital

Completed

Dietary Therapy in Dialysis Patients

End Stage Renal Disease on Dialysis

Taiwan
Liu, Liu-Yin

Completed

Explore the Effectors of The Transtheoretical Model on Nutritional Education in Patients on Hemodialysis

End-Stage Kidney Disease | Hyperphosphatemia

Taiwan
National Taiwan University Hospital

Unknown

Aluminum and Auditory Function in ESRD

End-Stage Renal Disease (ESRD)

Taiwan

Clinical Trials on Cholesterol Ester Storage Disease in Taiwan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United States

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations